Connect with us


Ocular Technologies Changes Hands for $40M+




The deal is expected to close this year.

Private equity firm Auven Therapeutics is selling portfolio company Ocular Technologies Sarl to India-based Sun Pharmaceutical Industries.

Ocular Technologies holds the rights to Seciera, a drug being developed for the treatment of dry eye disease. Seciera is currently being evaluated in a Phase 3 trial.

In the transaction, Auven will receive an upfront payment of $40 million plus “substantial contingent development and sales milestones.” Auven will also receive tiered royalties on global sales of Seciera.

“We believe that the Sun Pharma team has the ophthalmology expertise, the corporate focus and the commercial resources to launch Seciera aggressively in the U.S. and major global markets,” said Stephen Evans-Freke, co-founder and managing general partner of Auven Therapeutics. “We are confident Sun will optimize Seciera’s impact on a large, rapidly growing disease indication that is clearly underserved by currently available treatment options.”


Jerry Peter, vice-president and head of Sun Ophthalmics, said his unit hopes to “bring Seciera to ophthalmologists and optometrists globally, the market for which is estimated to touch $5 billion worldwide by 2020,” the Business Standard reports.

The deal is expected to close before the end of 2016.

Read the press release

Read more at the Business Standard



Turn Patients Into Loyal Eyewear Shoppers

80% of patients are browsing eyewear online, are you influencing patients online before your competition? Join thousands of practices thriving with Optify, voted the #1 optical sales tool by EyeVote. Empower your opticians to save time, increase optical revenue, and maximize your EHR data and website with a seamless optical plug-in that keeps patients buying from YOU! Now through August 31st receive a $25 UberEats® gift card when you complete a 15 min demo. Book your demo here..

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular

Link partner: indobet autowin88 vegasslot77 mantra88 ligasedayu warungtoto login sbobet vegas4d indobet ingatbola88 ligaplay dewagg hoki368 qqnusa ligagg zeus138 bro138 bos88 ligaciputra